Navigation Links
Vystar® Corporation Spotlights Advantages of Vytex® NRL at the 13th Annual International Latex Conference
Date:7/27/2011

ATLANTA, July 27, 2011 /PRNewswire/ -- Vystar® Corporation (OTCBB: VYST), creators of Vytex® Natural Rubber Latex (NRL), a patented, all-natural raw material that significantly reduces antigenic proteins and other non-rubber particles found in natural rubber latex, will present a technical paper at the 13th International Latex Conference (ILC) on July 27, 2011 titled "Further Development of Vytex® Natural Rubber Latex Leads to Strong Niche Market Advances."  Matt Clark, Vystar's Vice President of Technical Sales, will address attendees at the ILC, and will present with leaders in the latex industry such as R. T. Vanderbilt Co. Inc., Kraton Innovation Center, BASF, and distinguished chemistry education centers such as Penn State University and The Ohio State University.

The paper notes that Vytex NRL has proven to be a versatile material offering numerous advantages across a broad variety of applications.  Vytex is currently used in the production of finished goods from high-end jewel tone balloons that are brighter and retain air better, to low-odor foams for pillows and mattresses, low-protein adhesives with superior adhesion properties, and condoms and gloves that have received FDA 510(k) clearance.  The low non-rubber properties comply with the new ASTM D1076-10 category 5 classification, and as a result of the cleaner material properties, use of Vytex NRL can help dipped goods producers increase their product quality as well as reduce water and energy consumption by eliminating the need for additional leaching steps to reduce protein levels. To read the paper in its entirety, please visit the following link:

http://bit.ly/riQyQ0

Bill Doyle, Chairman and Chief Executive Officer, commented: "This presentation highlights Vytex's proven versatility and numerous advantages across a broad range of applications.  Our goal through giving these presentations is to educate our pe
'/>"/>

SOURCE Vystar Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Vystar® Corporation Appoints Joanne Kearney as Vice President of Marketing
2. Vystar® Corporation Secures a $3M Credit Facility to Fund Growth
3. CVS Caremark Corporation to Hold Second Quarter 2011 Conference Call
4. Luminex Corporation Receives U.S. FDA Clearance for New, Front Line Respiratory Viral Panel Test
5. Biomerix Corporation and Gel Company Announce Strategic Distribution Agreement
6. Luminex Corporation Second Quarter Earnings Release Scheduled for August 8, 2011
7. QuantRx Biomedical Corporation Provides Corporate Update
8. American Scientific Resources and School Health Corporation to Supply The Disintegrator™ Needle Destruction Device to Texas School District
9. China Medicine Corporation to Restate Financial Statements for 2006 and 2007
10. CVS Caremark Corporation Announces Quarterly Dividend
11. Luminex Corporation Completes Acquisition of EraGen Biosciences, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... EDISON, N.J. , March 5, 2015  ContraVir ... company focused on the development and commercialization of targeted ... the 27 th Annual ROTH Conference, to be ... CA. James Sapirstein , ... Company,s business during his live presentation and will be ...
(Date:3/5/2015)... March 5, 2015 According to ... by Product (Systems and Disposables), by Type (Invasive, Minimally ... Home and Ambulatory Sites) - Analysis & Global Forecast ... is expected to reach $1,107.4 Million by 2019 from ... at a CAGR of 4.5% during the forecast period. ...
(Date:3/5/2015)... Denmark , March 5, 2015 ... that applies its innovative TransCon technology to address ... present two posters at the ENDO 2015 conference ... The posters will be presented on Thursday, March ... is being held from 1:00pm-3:00pm PST, and are ...
Breaking Medicine Technology:ContraVir to Present at 27th Annual ROTH Conference 2Hemodynamic Monitoring Systems Market Worth $1,107.4 Million by 2019 2Hemodynamic Monitoring Systems Market Worth $1,107.4 Million by 2019 3Hemodynamic Monitoring Systems Market Worth $1,107.4 Million by 2019 4Ascendis Pharma to Present at ENDO 2015 2
... Worldwide, MENLO PARK, Calif., Nov. 15 ... global Phase III clinical program to,evaluate the efficacy ... program, which includes the COGENT-1 and COGENT-2 trials, ... in the United States, Canada,Europe and South America. ...
... Calif., Nov. 15 BiPar,Sciences, Inc., a privately ... it has initiated a Phase 2 study of ... breast,cancer that do not express the estrogen, progesterone ... Phase 2 trial in this indication-which,represents a major ...
Cached Medicine Technology:Cogentus to Launch Phase III Program of Novel Combination Product Designed to Reduce Bleeding Side Effect of Antiplatelet Therapy 2BiPar Begins Phase 2 Study of Lead PARP Inhibitor in Triple-Negative Breast Cancer Based on Overexpression Biomarker Data 2BiPar Begins Phase 2 Study of Lead PARP Inhibitor in Triple-Negative Breast Cancer Based on Overexpression Biomarker Data 3
(Date:3/5/2015)... Testosterone lawsuits ( http://www.testosteronelawsuithub.com/ ) filed ... strokes and other serious cardiovascular events due to their ... forward in the federal multidistrict litigation now underway in ... a Case Management Order issued on March 3rd, the ... master pleadings in the proceeding. Among other things, the ...
(Date:3/5/2015)... 2015 On March 2, 2015, NBC ... on the Rise, Plastic Surgeons Say,” that comments on ... for Aesthetic Plastic Surgery and the American ... a year-over-year doubling of surgical butt augmentations performed in ... the article, this increase can be attributed to the ...
(Date:3/5/2015)... HMP Communications Holdings , ... education, announced today its acquisition of the ... medical conference designed for health care providers dedicated ... amputation due to vascular disorders. The 5-year-old ... publications and CME activities across therapeutic fields such ...
(Date:3/5/2015)... Venice, FL (PRWEB) March 05, 2015 ... their 15th annual listing of “Pros to Know” in ... announce that two members of MEBC’s leadership team were ... Rhodes were nominated and received this award due to ... use of innovative methods for meeting and resolving client ...
(Date:3/5/2015)... 2015 Leading nutritional supplement provider ... Sports Festival and Arnold Fitness EXPO in ... will host a display booth featuring free samples of ... its highly-popular, class-leading fat burner Synedrex. The company will ... that utilize its top-of-the-line supplements and miniature action figures ...
Breaking Medicine News(10 mins):Health News:Testosterone Lawsuits Move Forward, as Bernstein Liebhard LLP Comments on Most Recent Order Issued in Federal Litigation 2Health News:Testosterone Lawsuits Move Forward, as Bernstein Liebhard LLP Comments on Most Recent Order Issued in Federal Litigation 3Health News:Testosterone Lawsuits Move Forward, as Bernstein Liebhard LLP Comments on Most Recent Order Issued in Federal Litigation 4Health News:The Kim Kardashian and Jennifer Lopez Effect: Butt Augmentations Double from 2013 to 2014 2Health News:HMP Holdings Acquires The Amputation Prevention Symposium (AMP) 2Health News:HMP Holdings Acquires The Amputation Prevention Symposium (AMP) 3Health News:MEBC Leaders Awarded Supply Demand Chain Executive Pros to Know Title For 2015 2Health News:Metabolic Nutrition Exhibiting at 2015 Arnold Sports Festival and Fitness EXPO This Week 2
... test by using EEG can predict whether a person ... by Leslie S. Prichep of the New York University School ... 44 patients and followed these people for a decade. The ... would develop dementia. ,Dementia is a brain disorder that causes ...
... research from the National Institute of Diabetes and Digestive and ... shown stabalisation of annual increases from 5 to 10 ... there is still a dramatic racial disparity. , ... than 1 percent since 1999, compared to an average 5 ...
... cancer vaccine trial against Melanoma which is a type ... vaccine developed by Antigenics.// The vaccine trial of Oncophage ... the required statistically significance results compared to prolongation in ... any better results compared to other cancer treatments. ...
... a near-pandemic condition that threatens millions with loss of ... atherosclerotic plaque in the arteries outside your heart.// Stem ... blood vessels and grow new ones thus restoring blood ... Ltd, a private, multinational company focuses on using stem ...
... inflammation according to scientists. Inflammation has a role to ... cardiovascular disease, diabetes, obesity, Alzheimer’s besides infections//. , ... said: “Practically every common disease involves an inflammation component,” ... Research (SFBR) in San Antonio., ,“So the discovery ...
... following ace cricketer Sachin Tendulkar's and several other players complaining ... the sports arena//. ,Tennis elbow, or lateral epicondylitis ... where the outer part of the elbow becomes painful and ... or a direct bang. The problem occurs following overuse of ...
Cached Medicine News:Health News:US Kidney Failure Rates show Stabilization After 20-Year Climb 2Health News:Tennis elbow not new among cricketers, say experts 2
... inhalers., ,ACE ensures prompt, effective delivery ... versatile design allows it to be used ... an endotracheal airway or resuscitation bag and ... be used in conjunction with an incentive ...
With ten colors available, Spectrums line of Color-Coded Fiberoptic Light Cables makes it easy to track by department....
... four models in proven halogen technology and ... find the right solution for every application: ... combination of two or three mobile lamps ... an on/off switch on the lamp housing, ...
Advanced Lighting System with Multi-Lamp Design providing Surgeon Focus Control and Extended, Variable Depth of Field over greater working distances. High Intensity, Cool Beam Temperature...
Medicine Products: